This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,720.65 firm-fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets, a specialty medication. The contract has an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience and capabilities in distributing a wide array of critical medical commodities make it a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.
Generated 2/27/25, 10:05 AM